127 related articles for article (PubMed ID: 36353988)
21. Modification of the cytoprotective protein C pathway during Dengue virus infection of human endothelial vascular cells.
Cabello-Gutiérrez C; Manjarrez-Zavala ME; Huerta-Zepeda A; Cime-Castillo J; Monroy-Martínez V; Correa BB; Ruiz-Ordaz BH
Thromb Haemost; 2009 May; 101(5):916-28. PubMed ID: 19404546
[TBL] [Abstract][Full Text] [Related]
22. Characterization of thrombophilia-related plasmas evaluated by anticoagulants-mediated thrombin and plasmin generation assays.
Hashimoto N; Ogiwara K; Matsumoto T; Furukawa S; Takeyama M; Nogami K
Blood Coagul Fibrinolysis; 2022 Sep; 33(6):327-336. PubMed ID: 35981254
[TBL] [Abstract][Full Text] [Related]
23. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
[TBL] [Abstract][Full Text] [Related]
24. Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand.
Bae JS; Rezaie AR
Thromb Haemost; 2008 Jul; 100(1):101-9. PubMed ID: 18612544
[TBL] [Abstract][Full Text] [Related]
25. Development and application of an automated chromogenic thrombin generation assay that is sensitive to defects in the protein C pathway.
Green L; Safa O; Machin SJ; Mackie IJ; Ryland K; Cohen H; Lawrie AS
Thromb Res; 2012 Nov; 130(5):780-4. PubMed ID: 22265675
[TBL] [Abstract][Full Text] [Related]
26. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O
Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790
[TBL] [Abstract][Full Text] [Related]
27. An in vitro analysis of the combination of hemophilia A and factor V(LEIDEN).
van 't Veer C; Golden NJ; Kalafatis M; Simioni P; Bertina RM; Mann KG
Blood; 1997 Oct; 90(8):3067-72. PubMed ID: 9376587
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of thrombomodulin-thrombin-activated protein C pathway as a mechanism for SARS-CoV-2 induced endotheliopathy and microvascular thrombosis.
Agarwal S; Cohen CT; Zobeck M; Jacobi PM; Sartain SE
Thromb Update; 2022 Aug; 8():100116. PubMed ID: 38620965
[TBL] [Abstract][Full Text] [Related]
29. Effects of oral contraceptives on hemostasis and thrombosis.
Rosing J; Tans G
Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
[TBL] [Abstract][Full Text] [Related]
30. Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling.
Riewald M; Ruf W
J Biol Chem; 2005 May; 280(20):19808-14. PubMed ID: 15769747
[TBL] [Abstract][Full Text] [Related]
31. The protein C pathway and sepsis.
Della Valle P; Pavani G; D'Angelo A
Thromb Res; 2012 Mar; 129(3):296-300. PubMed ID: 22154246
[TBL] [Abstract][Full Text] [Related]
32. Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions.
Mosnier LO; Yang XV; Griffin JH
J Biol Chem; 2007 Nov; 282(45):33022-33. PubMed ID: 17872949
[TBL] [Abstract][Full Text] [Related]
33. A direct thrombin inhibitor suppresses protein C activation and factor Va degradation in human plasma: Possible mechanisms of paradoxical enhancement of thrombin generation.
Kamisato C; Furugohri T; Morishima Y
Thromb Res; 2016 May; 141():77-83. PubMed ID: 26974491
[TBL] [Abstract][Full Text] [Related]
34. [Physiologie and cellular regulation of the protein C system].
Vincenot A; Gaussem P
Ann Biol Clin (Paris); 1997; 55(1):17-24. PubMed ID: 9099247
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of thrombomodulin-mediated conversion of protein C to APC: translation from in vitro to in vivo.
Carnemolla R; Patel KR; Zaitsev S; Cines DB; Esmon CT; Muzykantov VR
J Immunol Methods; 2012 Oct; 384(1-2):21-4. PubMed ID: 22750541
[TBL] [Abstract][Full Text] [Related]
36. Fibrinogen γ' increases the sensitivity to activated protein C in normal and factor V Leiden plasma.
Omarova F; Uitte de Willige S; Simioni P; Ariëns RA; Bertina RM; Rosing J; Castoldi E
Blood; 2014 Aug; 124(9):1531-8. PubMed ID: 24951429
[TBL] [Abstract][Full Text] [Related]
37. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Rosing J; Tans G; Nicolaes GA; Thomassen MC; van Oerle R; van der Ploeg PM; Heijnen P; Hamulyak K; Hemker HC
Br J Haematol; 1997 Apr; 97(1):233-8. PubMed ID: 9136971
[TBL] [Abstract][Full Text] [Related]
38. Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates.
Gruber A; Fernández JA; Bush L; Marzec U; Griffin JH; Hanson SR; DI Cera E
J Thromb Haemost; 2006 Feb; 4(2):392-7. PubMed ID: 16420571
[TBL] [Abstract][Full Text] [Related]
39. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
[TBL] [Abstract][Full Text] [Related]
40. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
